Screening for Cervical Cancer
Authors: Evelyn P. Whitlock
Journal: Annals of Internal Medicine (2012)

Letters17 April 2012Screening for Cervical CancerEvelyn P. Whitlock, MD, MPH, Kimberly K. Vesco, MD, MPH, Jennifer S. Lin, MD, MCR, Michelle Eder, PhD, and Brittany U. Burda, MPHEvelyn P. Whitlock, MD, MPHFrom Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227.Search for more papers by this author, Kimberly K. Vesco, MD, MPHFrom Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227.Search for more papers by this author, Jennifer S. Lin, MD, MCRFrom Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227.Search for more papers by this author, Michelle Eder, PhDFrom Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227.Search for more papers by this author, and Brittany U. Burda, MPHFrom Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-156-8-201204170-00015 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We thank Dr. Ronco and colleagues for pointing out our error in contrasting a higher cumulative cancer detection after cotesting in ARTISTIC with the opposite pattern in other cotesting trials. This error fortunately was only in the manuscript and not in our draft report that the U.S. Preventive Services Task Force used for its deliberations. The error was introduced when we omitted proportional cancer results from tables as we were editing to fit these data within space constraints for dissemination products, including the manuscript. The error has been corrected to indicate that cotesting trials tended to find fewer ...References1. Correction: Liquid-based cytology and human papillomavirus screening for cervical cancer. Ann Intern Med. 2012;156:71-2. LinkGoogle Scholar2. Rebolj M, Lynge E. Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening. Br J Cancer. 2010;103:310-4. [PMID: 20628384] CrossrefMedlineGoogle Scholar3. Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE. How to evaluate emerging technologies in cervical cancer screening? Int J Cancer. 2009;125:2489-96. [PMID: 19626591] CrossrefMedlineGoogle Scholar4. Ogilvie GS, van Niekerk D, Krajden M, Ceballos K, Ehlen TG, Martine RE, et al. HPV FOCAL: Round one results of a cervical cancer screening trial. Presented at International Papillomavirus Conference and Clinical Workshop, Berlin, Germany, 17–22 September 2011. Google Scholar5. Ronco G, Miejer C. HPV screening: available data and recommendations for clinical practice. Curr Cancer Ther Rev. 2010;6:104-9. CrossrefGoogle Scholar6. Katki HA, Wentzensen N. How might HPV testing be integrated into cervical screening? Lancet Oncol. 2012;13:8-10. [PMID: 22177578] CrossrefMedlineGoogle Scholar7. Kulasingam S, Havrilesky L, Ghebre R, Myers ER. Screening for Cervical Cancer: A Decision Analysis for the United States Preventive Services Task Force. Agency for Healthcare Research and Quality; 2011. AHRQ publication no. 11-05157-EF-1. Google Scholar8. Saraiya M, Berkowitz Z, Yabroff KR, Wideroff L, Kobrin S, Benard V. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Arch Intern Med. 2010;170:977-85. [PMID: 20548011] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Evelyn P. Whitlock, MD, MPH; Kimberly K. Vesco, MD, MPH; Jennifer S. Lin, MD, MCR; Michelle Eder, PhD; Brittany U. Burda, MPHAffiliations: From Center for Health Research, Kaiser Permanente Northwest, Portland, OR 97227.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-1382. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoLiquid-Based Cytology and Human Papillomavirus Testing to Screen for Cervical Cancer: A Systematic Review for the U.S. Preventive Services Task Force Evelyn P. Whitlock , Kimberly K. Vesco , Michelle Eder , Jennifer S. Lin , Caitlyn A. Senger , and Brittany U. Burda Correction: Liquid-Based Cytology and Human Papillomavirus Screening for Cervical CancerScreening for Cervical Cancer Guglielmo Ronco , Chris J.L. Meijer , Jack Cuzick , Paolo Giorgi-Rossi , Julian Peto , Nereo Segnan , and Joakim Dillner Metrics 17 April 2012Volume 156, Issue 8Page: 605-606KeywordsBiopsyCancer preventionCancer screeningCell biologyCervical cancerHuman papillomavirusResearch designRisk managementSystematic reviewsTriage ePublished: 17 April 2012 Issue Published: 17 April 2012 Copyright & PermissionsCopyright © 2012 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...